Trial intelligence / Profile preview

PA101 in refractory chronic cough (IPF and CIC)

NCT02412020Phase 2Completed

Sponsor
Patara Pharma
Start
Feb 2015
Primary completion
Jan 2016
Modality
Small Molecules
Countries
2
01

Overview

A Phase 2 trial of sodium cromoglycate in chronic cough, sponsored by Patara Pharma. Started Feb 2015; status: completed.

02

Drugs

sodium cromoglycate
03

Conditions

chronic cough

Beyond the preview

Go deeper on NCT02412020.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02412020.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call